A five-center case–control study found that METTL14 gene rs298982 G/A and rs1064034 T/A were significantly associated with a reduced risk of ALL in children [128]. METTL14 may be a potential biomarker for the prognosis of ALL. The gene discussed is METTL14; the disease is acute lymphoblastic leukemia.